Benchling, which gives cloud-based software program to handle biotech R&D, raises $200M led by Sequoia Capital International Equities at $4B valuation, 5x its worth in Might — Sajith Wickramasekara was simply 24 when he made the reduce for the Forbes 30 Underneath 30 record for his biotech R&D startup, Benchling.